Life Sciences

Rethinking MedTech Strategy in a Volatile Trade Landscape
The 2025 U.S. tariff reforms have disrupted global MedTech supply chains, forcing companies to rethink
Accelerating Clinical Trials in a Complex R&D Landscape
Despite breakthrough innovations in personalized medicine and digital therapeutics, life sciences companies still struggle to
Turning Connected Device Data into Revenue: A MedTech Evolution
As medical devices become smarter and more connected, MedTech companies are sitting on a goldmine